17

Arcadia Biosciences IncMUN Arcadia Stock Report

Last reporting period 30 Jun, 2024

Updated —

Last price

Market cap $B

0.004

Micro

Exchange

XMUN - Boerse Muenchen

17DN.MU Stock Analysis

17

Uncovered

Arcadia Biosciences Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

30/100

Low score

Market cap $B

0.004

Dividend yield

Shares outstanding

0.616 B

Arcadia Biosciences Inc is a US-based company operating in Food Products industry. The company is headquartered in Davis, California and currently employs 58 full-time employees. The company went IPO on 2015-05-15. Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The firm is engaged in developing crop improvements, primarily in wheat, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company is using non-genetically modified (non-GMO) advanced breeding techniques to develop the products. The firm's product portfolio includes GoodWheat Consumer Products, Zola Coconut Water, ProVault Topical Pain Relief, SoulSpring Body Care and Saavy Naturals Body Care. Its GoodWheat portfolio of specialty wheat ingredients delivers health benefits with advanced nutritional profiles. ProVault’s tetrahydrocannabinol (THC)-free, cannabidiol (CBD)-infused blend of natural ingredients and fast-acting cooling agents are designed to relieve muscle and joint pain and soothe skin.

View Section: Eyestock Rating